- Research article
- Open Access
LM14 defined medium enables continuous growth of Trypanosoma cruzi
BMC Microbiology volume 14, Article number: 238 (2014)
Trypanosoma cruzi, the etiologic agent of Chagas disease, alternates between distinct morphological and functional forms during its life cycle. Axenic multiplication and differentiation processes of this protozoan parasite can be reproduced in vitro, enabling the isolation and study of the different evolutionary forms. Although there are several publications attempting the cultivation of T. cruzi under chemically defined conditions, in our experience none of the published media are capable of maintaining T. cruzi in continuous growth.
In this work we modified a known chemically defined medium for Trypanosoma brucei growth. The resulting LM14 and LM14B defined media enabled cultivation of five different strains of T. cruzi for more than forty passages until now. The parasite′s biological characteristics such as morphology and differentiation to metacyclic trypomastigotes were maintained when defined media is used.
The establishment of a defined medium for T. cruzi cultivation is an important tool for basic biological research allowing several different approaches, providing new perspectives for further studies related to cell biology of this parasite.
Chagas disease is a serious illness discovered by Carlos Chagas in 1909 , which is caused by the protozoan parasite Trypanosoma cruzi. About 7 to 8 million people are infected worldwide, mostly in Latin America where Chagas disease is endemic. In 2008, Chagas disease killed more than 10,000 individuals . T. cruzi is usually transmitted to humans by the infected feces of blood-sucking triatomine bugs, although the parasites can also be transmitted through unconventional ways, including blood transfusions, organ transplants, congenital factors, laboratory accidents and oral transmission by ingestion of contaminated food .
T. cruzi undergoes remarkable morphological and physiological changes during development in both insect and mammalian hosts, adopting four distinct forms: epimastigotes and metacyclic trypomastigotes in the invertebrate vector and amastigotes and bloodstream trypomastigotes in vertebrate hosts . Epimastigotes and amastigotes are replicative forms, whereas metacyclic and bloodstream trypomastigotes are infective, non-replicative forms.
Analysis of differentiation processes such as metacyclogenesis (differentiation from epimastigotes to metacyclic trypomastigotes) that lead to infectivity are of great interest. This differentiation can be reproduced in vitro–, making it possible to isolate intermediate forms and study the time course of this process. Although in vitro metacyclogenesis is conducted under chemically defined conditions, the cultivation of epimastigote forms (pre-differentiation stage) is carried on in a complex high nutritive medium called LIT (Liver Infusion Tryptose) supplemented with 10% fetal bovine serum (FBS) ,. Several components of this medium have an unknown composition, including yeast extract, liver infusion, tryptose and FBS. These components may contain growth factors, vitamins, hormones, proteins, lipids or other factors that can influence many biological aspects of the parasite. Furthermore, the quality and origin of the animal sources of these components are highly variable. These variations can potentially affect growth and differentiation rates, as well as responses to drugs, hindering the analysis of experimental results conducted in this context.
Use of a chemically defined medium for the cultivation of T. cruzi could improve the current scenario helping to develop more uniform and standardized assays. For example, in a drug discovery context, it would bring more reproducibility and reliability to the testing of new trypanocidal drugs, as well as studying their effects and their mechanisms of action in this parasite –. In addition, use of a defined medium is essential for many useful assays, such as perturbation of medium components, cellular metabolic labeling and measurement of metabolites secreted by cells in the medium.
Several articles have already been published showing the cultivation of different strains of T. cruzi epimastigotes in defined media. In 1977, Azevedo and Roitman published a research note  communicating the continuous cultivation of Y strain in a defined medium – AR-103 – which was developed based on a previous defined medium for cultivation of T. brucei procyclic cells named HX25 . In 1975, Anderson and Krassner , as well as Cross and coworkers , showed successful cultivation of Costa Rica and Sonya strains, respectively, in HX25 defined medium. Avila and coworkers cultivated strains Y, Ma, Fl and Marin-1 of T. cruzi in a defined medium containing only D-glucose, inorganic salts, some vitamins, nucleotides and bovine liver catalase . Later they developed a minimal medium based on the previous, where nucleotides and vitamins had been excluded . However, these results were criticized by O’Daly and Rodriguez , since they showed the existence of 25 to 30 protein bands as well as DNA and RNA polymers contaminating the solution of bovine liver catalase used in the medium.
Thereafter, few published reports showed the cultivation of T. cruzi in a defined medium, and all of them only for a single passage, highlighting the challenge of continuously cultivating this parasite over long periods under defined conditions.
In the present work we demonstrate a continuous cultivation of T. cruzi epimastigote cells in two defined media derived from HX25M , named LM14 and LM14B. With these media, we cultivate five different strains of T. cruzi for more than forty passages. Morphology in defined conditions was maintained, as well as the parasite′s ability to differentiate to infective forms. Defined media described herein are powerful tools, indispensable for the application of several methods that could not be performed using non-defined media.
Results and discussion
HX25M and AR-103 media are not sufficient for T. cruzi cultivation
LITB+FBS is a complex high nutritive medium in which T. cruzi is routinely cultivated. The high complexity of the medium makes it infeasible to modify, removing or replacing its components. For this purpose, we tested the growth and maintenance of T. cruzi cells in both defined media AR-103 and HX25M. HX25M was developed to cultivate T. brucei cells , and has also been used to cultivate T. cruzi,, while AR-103 was developed based on HX25M and is used only for T. cruzi cultivation .
To evaluate the growth rate of cells cultivated in defined media, AR-103 and HX25M media were tested for T. cruzi cultivation (strain Dm 28c). Growth rates after three days of cultivation were compared with LITB+FBS medium, the routinely used medium for T. cruzi cultivation, and LITB without FBS, once FBS is absent in defined media. Cultures were maintained over five passages (Figure 1), all starting from 1e + 06 cells/ml. After the fourth passage, there was no cell growth in both HX25M or AR-103, indicating that these media do not support T. cruzi Dm 28c cell growth in these conditions. We obtained similar results in independent experiments performed using different batches of media at different times and using different types of flasks and plates (data not shown).
Putrescine allows continuous growth of T. cruzi in defined media
T. cruzi epimastigotes are auxotrophic for diamines, such as putrescine since T. cruzi, unlike other trypanosomatids, lacks the genes encoding either ornithine decarboxylase or arginine decarboxylase (ODC and ADC), enzymes responsible for putrescine biosynthesis –. Diamines are essential for cell proliferation, differentiation and macromolecular synthesis . T. cruzi is able to convert exogenous putrescine to trypanothione and cadaverine to homotrypanothione, antioxidants which are unique to the kinetoplastids and fulfill many of the roles ascribed to glutathione in other eukaryotic cells .
AR-103 and HX25M media lack diamines in their formulations, requiring the addition of at least one of them. Therefore, we tested cultivation of T. cruzi in defined media supplemented with 10 micromolar of putrescine (HX25M+P and AR-103+P). Figure 2 shows that parasites cultivated in AR-103+P died after the fourth passage (dashed line), whereas parasites in HX25M+P exhibited continuous growth, with increasing growth rate after several passages (green line).
These results show that defined media AR-103 and HX25M were not sufficient for continuous cultivation of T. cruzi cells, contradicting the results obtained by Azevedo and Roitman , Anderson and Krassner  and Cross et al. , being putrescine an essential compound for this purpose. AR-103 medium, even with putrescine, does not sustain continuous growth of T. cruzi in our hands.
Putrescine is greater than 97% pure and since addition of this compound alone, to a final concentration of 10 micromolar, was sufficient to convert medium from non-growth sustaining to growth sustaining we can rule out that any contaminant as being responsible for the acquired growth.
Biopterin accelerates T. cruzi growth in defined medium
Biopterin is a biologically significant pterin that functions as an essential cofactor for several enzymes involved in processes including hydroxylations, ether-lipid cleavage, and nitric oxide synthase –. Some trypanosomatids, like Leishmania, Crithidia and T. brucei, are unable to synthesize the pterin moiety from GTP (guanosine triphosphate) and thus must acquire pteridines from the host by salvage mechanisms –.
Biopterin was added to defined medium, with (HX25M+P+B) or without (HX25M+B) putrescine, at a final concentration of 1 μM. The growth rate was measured by counting at every three days of cultivation for five passages. Biopterin was not sufficient for continuous cultivation of T. cruzi without putrescine (Figure 2, HX25M+B, red line), but addition of biopterin to HX25M+P medium significantly increased the growth rate of the parasites compared to medium without biopterin HX25M+P (P < 0.01) (Figure 2, HX25M+P+B, black line).
The results presented above show that putrescine is required for T. cruzi epimastigote cultivation and biopterin shows growth stimulation of these parasites. These modified media were named LM14 (HX25M+P) and LM14B (HX25M+P+B).
Comparisons between parasite growth curves in defined and complex media were obtained by cultivating epimastigote forms at an initial density of 1e + 06 cells/ml, until they reached stationary phase or cell death. Stationary growth phase was reached on the 7th day for LM14 (2.8e + 07 cells/ml) and LITB without FBS (3.4e + 07 cells/ml) (Figure 3). As observed in LITB+FBS cultures, stationary growth phase of parasites cultivated in LM14B is reached at the 5th day (3e + 07 cells/ml) (Figure 3). Although growth rate of parasites cultivated in LM14B is slower than in LITB+FBS, when compared to cells growing in LITB without FBS it is notably faster. This result suggests that LM14B defined medium is better suited for T. cruzi growth than the standard medium LITB when FBS is absent.
To verify whether there are any undefined protein and/or DNA fragment present, we performed a SDS-polyacrylamide electrophoresis as well as an agarose gel electrophoresis of tested medium (data not shown). Only a 60–70 kDa protein was observed, mass related to albumin , which is added to the defined medium (bovine serum albumin – BSA). Also we did not observe any DNA fragment in the defined media. These results indicate that there are no protein or DNA contaminants in the tested defined medium, at least with the sensibility reached by the detection methodology used.
Parasites cultivated in LM14 and LM14B defined media can differentiate in vitro into metacyclic trypomastigotes
In vitro metacyclogenesis was performed to test the biological capability of T. cruzi cells to differentiate after cultivation in the defined medium. Epimastigotes forms cultivated in LM14 defined medium showed a differentiation rate of about 30% to metacyclic trypomastigotes after 72 hours of differentiation, a similar differentiation rate found in parasites from LITB+FBS medium (about 32% of metacyclic trypomastigotes) under the same conditions. We also observed spontaneous metacyclic trypomastigote forms from the third day of culture in LM14 medium, before the stimuli for differentiation (Figure 4 upper panel, 5D EPI and STRESS). Interestingly, parasites cultivated in LM14B defined medium, although exhibiting a better growth rate than in LM14 and absence of spontaneous metacyclic trypomastigotes before the stress stimuli, they showed a much lower differentiation rate, about 18% of metacyclic trypomastigotes after 72 hours of differentiation. This event can be compared to that observed in Leishmania major, where a tetrahydrobiopterin (the active form of biopterin) deficiency in promastigote forms increased differentiation into the mammalian-infectious metacyclic promastigote form, probably indicating a role of pterins in resistance to oxidative stress, but the underlying mechanism remains obscure ,.
Although parasites from LM14B exhibit a lower differentiation rate compared to those in LITB+FBS, the process is still occurring in this condition and can be performed with parasites from LM14 medium with a higher differentiation rate. This represent a strong indication that the biological capabilities of T. cruzi in our defined medium are maintained.
We also analyzed the ultrastructure of T. cruzi epimastigotes cultivated in LITB+FBS, LITB without serum and LM14B media to verify possible morphological alterations in cells cultivated in defined medium, when compared with conventional complex medium. Analysis of T. cruzi ultrathin sections by transmission electron microscopy showed no visible alteration in cell shape or intracellular organelle content (data available in Additional file 1), showing that the morphology of T. cruzi cultivated in LM14B is maintained.
Different T. cruzi strains can be cultivated in LM14B defined medium
T. cruzi is a highly polymorphic specie. The biological, biochemical and genetic diversity of T. cruzi isolates has long been recognized –. Over the years, several approaches have been used to separate the T. cruzi population into different groups, or discrete typing units (DTUs). Recently, Zingales and coworkers reorganized by consensus the nomenclature of these DTUs as TcI-TcVI .
We selected strains from different DTUs to test their suitability to grow in LM14B defined medium. They were: Colombiana and Dm 28c (DTU I), Esmeraldo (DTU II), CL14 and CL Brener (DTU VI). Our findings clearly demonstrate that LM14B medium was efficient for cultivating all tested T. cruzi strains in defined conditions, even better than cultivation in LITB medium without FBS (Figure 5).
Our data report the development of a defined medium for T. cruzi cultivation. Despite previously published work reporting sustained cultivation of T. cruzi in defined medium, we could not reproduce such results. Therefore, to our knowledge, LM14 and LM14B are the only chemically defined medium capable of continuous axenic T. cruzi cultivation (more than forty passages until now for all the tested strains) while maintaining T. cruzi morphology and ability to differentiate. Both defined media described herein present important advances to study the cell biology of this parasite, since they enable metabolic labeling, drugs research and evaluation, metabolic studies, among other powerful methods, providing new perspectives for further studies related to T. cruzi biochemistry.
Defined media preparation
All components of both AR-103 and HX25M defined media were individually dissolved in appropriate solvent, at concentrations under each limit of solubility. The required amount of each component for 1 liter of medium was added to 500 ml of distilled water and mixed under constant agitation at room temperature until complete dissolution. After, the medium pH was adjusted to 7.2 and the volume was completed to 900 ml with water. The volume was set to 1 liter with water. Finally, the medium was sterilized using a 0.22 μm filter.
The final LM14B medium formulation and method of preparation can be found in Additional file 2.
Trypanosoma cruzi growth
The experiments were performed using the T. cruzi strain Dm 28c . Culture epimastigote forms were maintained at 28°C in LITB medium supplemented or not with 10% fetal bovine serum (FBS) ,, by passages every three days from an initial density of 1e + 06 cells/ml in fresh medium.
Cell cultures in defined media were obtained from cultures previously cultivated in LITB+FBS medium. In order to eliminate LITB+FBS medium before cultivation in defined media, cells were washed twice in sterile phosphate saline buffer (137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 1.5 mM KH2PO4). Media evaluation was performed with three biological replicates and passages every three days of 1e + 06 cells/ml. After confirmation of continuous and stable growth of cultures over several passages, a growth curve was obtained with three biological replicates, using an initial concentration of 1e + 06 cells/ml, and daily counting until cultures reached stationary phase, or until start of cell death.
All cultures were maintained in 15 ml conical centrifuge tubes, at a final volume of 3 ml. Epimastigote cells counts were performed using an automatic counter (Z2 Coulter® – Beckman Coulter).
To test the suitability of LM14B to maintain growth of different strains of T. cruzi, the CL14, CL Brener, Colombiana and Esmeraldo strains were tested . All were cultivated in LITB+FBS, LITB without FBS and LM14B medium with passages every three day from an initial density of 1e + 06 cells/ml in fresh medium. Cells were harvested from LITB+FBS media by centrifugation at 7,000 × g for 5 min at 20°C and washed in sterile phosphate saline buffer before starting the experiment.
Data were compared via two-way analysis of variance (ANOVA) followed by Bonferroni multiple range test for statistically significant differences at p < 0.05.
In vitro metacyclogenesis
Aiming to verify if biological characteristics of parasites are maintained in defined medium, we performed in vitro differentiation from epimastigotes forms (replicative) to metacyclic trypomastigotes forms (infective), a process known as metacyclogenesis . For this purpose, epimastigotes were harvested from LITB+FBS, LM14 and LM14B media after 5 days of culture (early stationary phase), by centrifugation at 7,000 × g for 5 min at 20°C. Epimastigotes were then submitted to nutritional stress by incubation at 28°C in TAU medium (190 mM NaCl, 17 mM KCl, 2 mM MgCl2, 2 mM CaCl2, 8 mM phosphate buffer pH 6.0) for 2 hours at a concentration of 5e + 08 cells/mL. Next, cultures were diluted 1:100 in TAU3AAG medium (TAU supplemented with 10 mM L-proline, 50 mM L-sodium glutamate, 2 mM L-sodium aspartate, and 10 mM D-glucose). After 96 h of incubation, differential counts between epimastigotes and metacyclic trypomastigotes forms were performed in Neubauer chamber to determine the differentiation rates.
CVPL responsible for conception of experimental design, for all the experiments performed, analysis and interpretation of data, and manuscript writing. MB was involved in defined medium elaboration, analysis and interpretation of data and revising the manuscript. FGK was involved in defined medium elaboration, analysis and interpretation of data and revising the manuscript. IMV responsible for revising the manuscript. MJS responsible for transmission electron microscopy data and revising the manuscript. CMP was involved in conception of experimental design and revising the manuscript. MAK made substantial contributions to conception of experimental design, and revising the manuscript. FKM responsible for conception of experimental design, for all the experiments performed, analysis and interpretation of data, and revising the manuscript. All authors read and approved the final manuscript.
Fetal bovine serum
HX25M medium supplemented with putrescine (named as LM14 in this article)
HX25M medium supplemented with biopterine
HX25M medium supplemented with putrescine and biopterine (named as LM14B in this article)
Discrete type units
Chagas C: Nova tripanozomiaze humana. Mem Inst Oswaldo Cruz. 1909, 1: 159-218. 10.1590/S0074-02761909000200008.
Chagas Disease. 2014
Kirchhoff LV: Epidemiology of American trypanosomiasis (Chagas disease). Adv Parasitol. 2011, 75: 1-18. 10.1016/B978-0-12-385863-4.00001-0.
De Souza W: Basic cell biology of Trypanosoma cruzi. Curr Pharm Des. 2002, 8: 269-285. 10.2174/1381612023396276.
Contreras VT, Salles JM, Thomas N, Morel CM, Goldenberg S: In vitro differentiation of Trypanosoma cruzi under chemically defined conditions. Mol Biochem Parasitol. 1985, 16: 315-327. 10.1016/0166-6851(85)90073-8.
Bonaldo MC, Souto-Padron T, de Souza W, Goldenberg S: Cell-substrate adhesion during Trypanosoma cruzi differentiation. J Cell Biol. 1988, 106: 1349-1358. 10.1083/jcb.106.4.1349.
Contreras VT, Araujo-Jorge TC, Bonaldo MC, Thomaz N, Barbosa HS, Meirelles MNSL, Goldenberg S: Biological aspects of the Dm28c Clone of Trypanosoma cruzi after metacyclogenesis in chemically defined media. Mem Inst Oswaldo Cruz. 1988, 83: 123-133. 10.1590/S0074-02761988000100016.
Camargo EP: Growth and differentiation in Trypanosoma cruzi. Rev Inst Med Trop Sao Paulo. 1964, 6: 93-100.
Goitia Aular M, de Boiso JF: Cultivo de Trypanosoma cruzi (cepa Elpidio Padrón) en un medio semidefinido Efecto de algunas variaciones en la composición y condiciones del mismo. Acta Científica Venez. 1982, 33: 488-496.
Kwon YK, Lu W, Melamud E, Khanam N, Bognar A, Rabinowitz JD: A domino effect in antifolate drug action in Escherichia coli. Nat Chem Biol. 2008, 4: 602-608. 10.1038/nchembio.108.
Vincent IM, Creek DJ, Burgess K, Woods DJ, Burchmore RJS, Barrett MP: Untargeted metabolomics reveals a lack of synergy between nifurtimox and eflornithine against Trypanosoma brucei. PLoS Negl Trop Dis. 2012, 6: e1618-10.1371/journal.pntd.0001618.
Creek DJ, Nijagal B, Kim D-H, Rojas F, Matthews KR, Barrett MP: Metabolomics guides rational development of a simplified cell culture medium for drug screening against Trypanosoma brucei. Antimicrob Agents Chemother. 2013, 57: 2768-2779. 10.1128/AAC.00044-13.
de Azevedo HP, Roitman I: Growth of the Y strain of Trypanosoma cruzi in an HX25-modified defined medium. J Parasitol. 1977, 63: 485-10.2307/3280006.
Cross GAM, Manning JC: Cultivation of Trypanosoma brucei sspp. in semi -defined and defined media. Parasitology. 1973, 67: 315-331. 10.1017/S0031182000046540.
Anderson SJ, Krassner SM: Axenic culture of Trypanosoma cruzi in a chemically defined medium. J Parasitol. 1975, 61: 144-145. 10.2307/3279125.
Cross GAM, Klein RA, Baker JR: Trypanosoma cruzi: growth, amino acid utilization and drug action in a defined medium. Ann Trop Med Parasitol. 1975, 69: 513-514.
Avila JL, Bretaña A, Casanova MA, Avila A, Rodriguez F: Trypanosoma cruzi: defined medium for continuous cultivation of virulent parasites. Exp Parasitol. 1979, 48: 27-35. 10.1016/0014-4894(79)90051-1.
Avila JL, Pérez-Kepp R, Bretaña A: A minimal medium for the cultivation of infective Trypanosoma cruzi epimastigotes. J Gen Microbiol. 1983, 129: 285-291.
O’Daly JA, Rodriguez MB: Protein and nucleotide contamination of bovine liver catalase used in culture medium explains growth of Trypanosoma cruzi. Trans R Soc Trop Med Hyg. 1987, 81: 1-2. 10.1016/0035-9203(87)90266-5.
Cross GAM, Klein RA, Linstea PJD: Utilization of amino acids by Trypanosoma brucei in culture: L-threonine as a precursor for acetate. Parasitology. 1975, 71: 311-313. 10.1017/S0031182000046758.
Hunter KJ, Le Quesne SA, Fairlamb AH: Identification and biosynthesis of N1, N9-bis(glutathionyl)aminopropylcadaverine (homotrypanothione) in Trypanosoma cruzi. Eur J Biochem. 1994, 226: 1019-1027. 10.1111/j.1432-1033.1994.t01-1-01019.x.
Ariyanayagam MR, Fairlamb AH: Diamine auxotrophy may be a universal feature of Trypanosoma cruzi epimastigotes. Mol Biochem Parasitol. 1997, 84: 111-121. 10.1016/S0166-6851(96)02788-0.
Carrillo C, Cejas S, González NS, Algranati ID: Trypanosoma cruzi epimastigotes lack ornithine decarboxylase but can express a foreign gene encoding this enzyme. FEBS Lett. 1999, 454: 192-196. 10.1016/S0014-5793(99)00804-2.
Tabor CW, Tabor H: Polyamines. Annu Rev Biochem. 1984, 53: 749-790. 10.1146/annurev.bi.53.070184.003533.
Fairlamb AH, Blackburn P, Ulrich P, Chait BT, Cerami A: Trypanothione: a novel bis(glutathionyl)spermidine cofactor for glutathione reductase in trypanosomatids. Science. 1985, 227: 1485-1487. 10.1126/science.3883489.
Tietz A, Lindberg M, Kennedy EP: A new pteridine-requiring enzyme system for the oxidation of glyceryl ethers. J Biol Chem. 1964, 239: 4081-4090.
Tayeh MA, Marletta MA: Macrophage oxidation of L-arginine to nitric oxide, nitrite, and nitrate. Tetrahydrobiopterin is required as a cofactor. J Biol Chem. 1989, 264: 19654-19658.
Kwon NS, Nathan CF, Stuehr DJ: Reduced biopterin as a cofactor in the generation of nitrogen oxides by murine macrophages. J Biol Chem. 1989, 264: 20496-20501.
Ong HB, Sienkiewicz N, Wyllie S, Fairlamb AH: Dissecting the metabolic roles of pteridine reductase 1 in Trypanosoma brucei and Leishmania major. J Biol Chem. 2011, 286: 10429-10438. 10.1074/jbc.M110.209593.
Beck JT, Ullman B: Nutritional requirements of wild-type and folate transport-deficient Leishmania donovani for pterins and folates. Mol Biochem Parasitol. 1990, 43: 221-230. 10.1016/0166-6851(90)90147-E.
Kidder GW, Dutta BN: The growth and nutrition of Crithidia fasciculata. J Gen Microbiol. 1958, 18: 621-638. 10.1099/00221287-18-3-621.
Sun S-F, Del Rosario NO: Size and shape of bovine serum albumin in acidic water-dioxane mixtures. J Am Chem Soc. 1970, 92: 1837-1839. 10.1021/ja00710a008.
Cunningham ML, Titus RG, Turco SJ, Beverley SM: Regulation of differentiation to the infective stage of the protozoan parasite Leishmania major by tetrahydrobiopterin. Science. 2001, 292: 285-287. 10.1126/science.1057740.
Nare B, Garraway LA, Vickers TJ, Beverley SM: PTR1-dependent synthesis of tetrahydrobiopterin contributes to oxidant susceptibility in the trypanosomatid protozoan parasite Leishmania major. Curr Genet. 2009, 55: 287-299. 10.1007/s00294-009-0244-z.
Macedo AM, Pena SD: Genetic variability of Trypanosoma cruzi: implications for the pathogenesis of Chagas disease. Parasitol Today. 1998, 14: 119-124. 10.1016/S0169-4758(97)01179-4.
Brisse S, Dujardin JC, Tibayrenc M: Identification of six Trypanosoma cruzi lineages by sequence-characterised amplified region markers. Mol Biochem Parasitol. 2000, 111: 95-105. 10.1016/S0166-6851(00)00302-9.
Lewis MD, Llewellyn MS, Gaunt MW, Yeo M, Carrasco HJ, Miles MA: Flow cytometric analysis and microsatellite genotyping reveal extensive DNA content variation in Trypanosoma cruzi populations and expose contrasts between natural and experimental hybrids. Int J Parasitol. 2009, 39: 1305-1317. 10.1016/j.ijpara.2009.04.001.
Zingales B, Andrade SG, Briones MRS, Campbell DA, Chiari E, Fernandes O, Guhl F, Lages-Silva E, Macedo AM, Machado CR, Miles MA, Romanha AJ, Sturm NR, Tibayrenc M, Schijman AG: A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI. Mem Inst Oswaldo Cruz. 2009, 104: 1051-1054. 10.1590/S0074-02762009000700021.
Brener Z, Chiari E: Morphological variations observed in different strains of Trypanosoma cruzi. Rev Inst Med Trop Sao Paulo. 1963, 5: 220-224.
We would like to thank Dr. Bruno Dallagiovanna Muniz, Dr. Alexandre Dias Tavares Costa and Michael Barrett for revising the manuscript and Carlos Robello for opening our eyes to Biopterin. The authors thank the Instituto Carlos Chagas/Fiocruz-PR, Program for Technological Development in Tools for Health-PDTIS-FIOCRUZ, Strategic program for support of health research (PAPES) and CAPES for use of its facilities and financial support.
The authors declare that they have no competing interests.
Authors’ original submitted files for images
Below are the links to the authors’ original submitted files for images.